GB0308604D0 - Pharmaceutical combinations for treating viral infections - Google Patents
Pharmaceutical combinations for treating viral infectionsInfo
- Publication number
- GB0308604D0 GB0308604D0 GBGB0308604.8A GB0308604A GB0308604D0 GB 0308604 D0 GB0308604 D0 GB 0308604D0 GB 0308604 A GB0308604 A GB 0308604A GB 0308604 D0 GB0308604 D0 GB 0308604D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- viral infections
- treating viral
- pharmaceutical combinations
- pharmaceutical
- combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0308604A GB2400553A (en) | 2003-04-14 | 2003-04-14 | Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof |
PCT/GB2004/001623 WO2004089383A1 (en) | 2003-04-14 | 2004-04-14 | Pharmaceutical combinations comprising lamivudine, stavudine and efavirenz for treating viral infections |
CL200401263A CL2004001263A1 (en) | 2003-04-14 | 2004-05-25 | PHARMACEUTICAL COMPOSITION THAT INCLUDES LAMIVUDINE, ESTAVUDINE AND EFAVIRENZO, OR DERIVATIVES OF THEM, PHARMACEUTICAL KIT; PROCEDURE FOR PREPARATION; AND USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF VIRAL INFECTIONS, |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0308604A GB2400553A (en) | 2003-04-14 | 2003-04-14 | Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0308604D0 true GB0308604D0 (en) | 2003-05-21 |
GB2400553A GB2400553A (en) | 2004-10-20 |
Family
ID=9956764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0308604A Withdrawn GB2400553A (en) | 2003-04-14 | 2003-04-14 | Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof |
Country Status (3)
Country | Link |
---|---|
CL (1) | CL2004001263A1 (en) |
GB (1) | GB2400553A (en) |
WO (1) | WO2004089383A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009106960A2 (en) * | 2008-02-27 | 2009-09-03 | Aurobindo Pharma Limited | Stable compositions of lamivudine, tenofovir and efavirenz |
WO2022053993A2 (en) * | 2020-09-12 | 2022-03-17 | Mylan Laboratories Limited | Treatments for sars-cov-2 infection (covid-19) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO4970782A1 (en) * | 1997-11-13 | 2000-11-07 | Merck & Co Inc | COMBINED THERAPY FOR THE TREATMENT OF AIDS |
US6455548B2 (en) * | 2000-02-28 | 2002-09-24 | Merck & Co., Inc. | 4-alkyl piperidinyl pyrrolidine modulators of chemokine receptor activity |
US20050065319A1 (en) * | 2000-12-19 | 2005-03-24 | Baroudy Bahige M. | Combination method for treating viral infections |
-
2003
- 2003-04-14 GB GB0308604A patent/GB2400553A/en not_active Withdrawn
-
2004
- 2004-04-14 WO PCT/GB2004/001623 patent/WO2004089383A1/en active Application Filing
- 2004-05-25 CL CL200401263A patent/CL2004001263A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004089383A1 (en) | 2004-10-21 |
CL2004001263A1 (en) | 2005-05-06 |
GB2400553A (en) | 2004-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL174685A0 (en) | Nucleoside compounds for treating viral infections | |
PL380828A1 (en) | Phosphoranians, amidomonophosphoranians, amidobisphosphoranians for treating virus diseases | |
IL184955A0 (en) | Tricyclic-nucleoside compounds for treating viral infections | |
PL376454A1 (en) | 1-acyl-pyrrolidine derivatives for the treatment of viral infections | |
IL174684A0 (en) | Nucleoside compounds for treating viral infections | |
EG27104A (en) | Pharmaceutical compounds | |
EP1594512A4 (en) | Compounds for the treatment of viral infection | |
IL178141A0 (en) | Combinations for treating hiv infection | |
GB0315657D0 (en) | Pharmaceutical compounds | |
IL173365A0 (en) | Piperazine derivatives for the treatment of hiv infections | |
IL203061A (en) | Halogenated benzamide compounds for treating viral infections | |
IL189792A0 (en) | Benzodiazepine derivatives for treating hepatitis c infection | |
HK1095036A1 (en) | Virus therapeutic drug | |
GB0308511D0 (en) | Pharmaceutical compounds | |
GB0329254D0 (en) | Treatment of viral infections | |
GB2411354B (en) | Use of Scutellaria for the treatment of viral infections | |
EP1626692A4 (en) | Compounds for the treatment of flaviviridae infections | |
EP1660116A4 (en) | Method of treating viral infections | |
AU2003303123A8 (en) | Dna vaccines against hantavirus infections | |
GB0317315D0 (en) | Pharmaceutical compounds | |
GB0329958D0 (en) | Treatment of viral infections | |
GB0313766D0 (en) | Pharmaceutical compounds | |
GB0308603D0 (en) | Pharmaceutical combinations for treating viral infections | |
AU2003237088A8 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
GB0301736D0 (en) | Pharmaceutical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1070814 Country of ref document: HK |
|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1070814 Country of ref document: HK |